Vasomune Therapeutics is a private biotechnology company developing the next generation of medicine. Our innovative approach focuses on combating vascular dysfunction and defending against illness by activating the Tie2 pathway Our company’s lead drug candidate targets a signaling molecule responsible for regulating the vascular response to injury (vascular leak) which is associated with a wide range of diseases such as Acute Respiratory Distress Syndrome (ARDS), Acute Kidney Injury, sepsis and Cardiopulmonary Bypass. Through pioneering the fight against vascular leak and by decreasing the activity of multiple proinflammatory factors, we can greatly increase the chances of patient health and success. For more, visit www.vasomune.com
View Top Employees from Vasomune IncWebsite | http://www.vasomune.com |
Revenue | $5 million |
Employees | 9 (4 on RocketReach) |
Founded | 2014 |
Address | 180 John St, Suite 305, Toronto, Ontario M5T 1X5, CA |
Phone | (647) 475-5660 |
Industry | Biotechnology, Pharmaceutical Manufacturing, Business Services General, Business Services, Science and Engineering, Drug Discovery, Life Science, Therapeutics, Health Care |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular Vasomune Inc employee's phone or email?
The Vasomune Inc annual revenue was $5 million in 2024.
Harold Kim is the Vice President Research and Scientific Affairs of Vasomune Inc.
4 people are employed at Vasomune Inc.
Vasomune Inc is based in Toronto, Ontario.
The NAICS codes for Vasomune Inc are [5417, 54171, 541714, 54, 541].
The SIC codes for Vasomune Inc are [87, 873].